I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Solca, Flavio
54
results:
Search for persons
X
Format
Online (54)
Mediatypes
Articles (Online) (35)
OpenAccess-fulltext (19)
Sorted by: Relevance
Sorted by: Year
?
1
Afatinib in paediatric patients with recurrent/refractory E..:
Geoerger, Birgit
;
Marshall, Lynley V.
;
Nysom, Karsten
...
European Journal of Cancer. 188 (2023) - p. 8-19 , 2023
Link:
https://doi.org/10.1016/..
?
2
Phase II trial of afatinib in patients with advanced urothe..:
Font, Albert
;
Mellado, Begona
;
Climent, Miguel A.
...
British Journal of Cancer. 130 (2023) 3 - p. 434-441 , 2023
Link:
https://doi.org/10.1038/..
?
3
Therapeutic impact of BET inhibitor BI 894999 treatment: ba..:
Tontsch-Grunt, Ulrike
;
Traexler, Paula-Elena
;
Baum, Anke
...
British Journal of Cancer. 127 (2022) 3 - p. 577-586 , 2022
Link:
https://doi.org/10.1038/..
?
4
Afatinib for the Treatment of Non-Small Cell Lung Cancer Ha..:
Yang, James Chih-Hsin
;
Schuler, Martin
;
Popat, Sanjay
...
Frontiers in Oncology. 12 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
5
An Unbiased Functional Genetics Screen Identifies Rare Acti..:
Chakroborty, Deepankar
;
Ojala, Veera K.
;
Knittle, Anna M.
...
Cancer Research Communications. 2 (2022) 1 - p. 10-27 , 2022
Link:
https://doi.org/10.1158/..
?
6
Genomic Analysis of Tumors from Patients with Glioblastoma ..:
Owen, Scott
;
Alken, Scheryll
;
Alshami, Jad
...
OncoTargets and Therapy. 15 (2022) - p. 367-380 , 2022
Link:
https://doi.org/10.2147/..
?
7
Comprehensive analysis of the ErbB receptor family in pedia..:
Varlet, Pascale
;
Bouffet, Eric
;
Casanova, Michela
...
Pediatric Blood & Cancer. 69 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1002/..
?
8
Case Report: Afatinib Treatment in a Patient With NSCLC Har..:
Zöchbauer-Müller, Sabine
;
Kaserer, Bettina
;
Prosch, Helmut
...
Frontiers in Oncology. 10 (2021) - p. , 2021
Link:
https://doi.org/10.3389/..
?
9
Combined targeting EGFR and SRC as a potential novel therap..:
Canonici, Alexandra
;
Browne, Alacoque L.
;
Ibrahim, Mohamed F. K.
...
Therapeutic Advances in Medical Oncology. 12 (2020) - p. 175883591989754 , 2020
Link:
https://doi.org/10.1177/..
?
10
Afatinib is active in osteosarcoma in osteosarcoma cell lin..:
Cruz-Ramos, Marlid
;
Zamudio-Cuevas, Yessica
;
Medina-Luna, Daniel
...
Journal of Cancer Research and Clinical Oncology. 146 (2020) 7 - p. 1693-1700 , 2020
Link:
https://doi.org/10.1007/..
?
11
Therapeutic Potential of Afatinib inNRG1Fusion-Driven Solid..:
Cadranel, Jacques
;
Liu, Stephen V.
;
Duruisseaux, Michaël
...
The Oncologist. 26 (2020) 1 - p. 7-16 , 2020
Link:
https://doi.org/10.1634/..
?
12
Correction to: Afatinib is active in osteosarcoma cell line:
Cruz-Ramos, Marlid
;
Zamudio-Cuevas, Yessica
;
Medina-Luna, Daniel
...
Journal of Cancer Research and Clinical Oncology. 146 (2020) 10 - p. 2719-2719 , 2020
Link:
https://doi.org/10.1007/..
?
13
Afatinib as a novel potential treatment option for NRG1 fus..:
Laskin, Janessa J.
;
Cadranel, Jacques
;
Renouf, Daniel John
...
Journal of Global Oncology. 5 (2019) suppl - p. 110-110 , 2019
Link:
https://doi.org/10.1200/..
?
14
Tumor Clonality and Resistance Mechanisms inEGFRMutation-Po..:
Kohsaka, Shinji
;
Petronczki, Mark
;
Solca, Flavio
.
Future Oncology. 15 (2018) 6 - p. 637-652 , 2018
Link:
https://doi.org/10.2217/..
?
15
P3.02b-003 Second-Line Afatinib versus Erlotinib for Patien..:
Felip, Enriqueta
;
Soria, Jean-Charles
;
Cobo, Manuel
...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S1186-S1187 , 2017
Link:
https://doi.org/10.1016/..
1-15